COVID-19 vaccine weekly safety report (12 August 2021)

12 August 2021 - To 8 August 2021, approximately 13.7 million vaccine doses have been given in Australia – 9.1 million ...

Read more →

New Alzheimer's drug aducanumab is dividing doctors and patients, as the TGA weighs up its risk-benefit profile

12 August 2021 - After a decades-long career as a biology teacher, John Rodgers applies the strict logic of a ...

Read more →

TGA head John Skerritt says NSW death toll would be much higher without AstraZeneca vaccine

11 August 2021 - The head of the national medical regulator says NSW would be recording “dozens” of covid deaths a ...

Read more →

TGA grants provisional determination to MSD's anti-viral COVID-19 treatment molnupiravir

10 August 2021 - On 9 August 2021 the Therapeutic Goods Administration granted provisional determination to MSD in relation to ...

Read more →

TGA provisionally approves Moderna’s COVID-19 vaccine

9 August 2021 - Today, the Therapeutic Goods Administration, granted provisional approval to Moderna Australia for its COVID-19 vaccine—Spikevax (elasomeran)—making ...

Read more →

COVID-19 vaccine: international collaboration

6 August 2021 - The Therapeutic Goods Administration has strong working relationships with a wide range of international agencies and ...

Read more →

New contraceptive pill: ‘safer’ Slinda pill with no blood clot risk, no periods available in Australia

8 August 2021 - A new generation contraceptive pill with no blood clot risks, that can be used by almost all ...

Read more →

Additional COVID-19 treatment for Australia

8 August 2021 - The Australian Government has secured an initial shipment of over 7,700 doses of the novel monoclonal ...

Read more →

Moderna vaccine set to be available in Australia by September

8 August 2021 - Australians will have a third vaccine option within weeks, with the country’s drug regulator set to ...

Read more →

Novavax booster doses to soon join stockpile

6 August 2021 - Novavax will apply for approval for its COVID-19 vaccine in Australia “within weeks” of making a ...

Read more →

COVID-19 vaccine weekly safety report (5 August 2021)

5 August 2021 - Three additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

Lupus drug will be ‘game changer’

5 August 2021 - The first targeted treatment for the debilitating auto-immune condition lupus could soon be available in Australia after ...

Read more →

ATAGI statement regarding vaccination of adolescents aged 12–15 years

2 August 2021 - Following the recent approval by the TGA for the provisional registration of the Comirnaty (Pfizer) COVID-19 vaccine ...

Read more →

COVID-19 vaccine weekly safety report (29 July 2021)

29 July 2021 - Over the last week, six additional cases of blood clots with low blood platelets have been assessed ...

Read more →

TGA international engagement strategy 2021-2025

26 July 2021 - The TGA's International Engagement Strategy 2021-2025 describes how working with our international regulatory counterparts will benefit Australians ...

Read more →